Ozempic (semaglutide) is prescribed for adults with type 2 diabetes. It’s given as an injection under the skin once per week. Your doctor will prescribe a starting dose and a maintenance (ongoing) ...
Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four weeks. Ozempic -- a once-weekly injectable formulation of semaglutide -- is ...
Ozempic is approved by the Food and Drug Administration (FDA) for certain uses in people with type 2 diabetes. It can be prescribed off-label to help with weight loss, but it’s not approved for this ...
The weekly injection was approved by the US Food and Drug Administration in 2017 for people with type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results